SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:lup.lub.lu.se:9da8e4cf-3092-48c5-aaed-478faf8eac0a"
 

Sökning: id:"swepub:oai:lup.lub.lu.se:9da8e4cf-3092-48c5-aaed-478faf8eac0a" > Thromboembolic and ...

Thromboembolic and bleeding risk in obese patients with atrial fibrillation according to different anticoagulation strategies

Patti, Giuseppe (författare)
University of Eastern Piedmont,University Hospital of Novara
Pecen, Ladislav (författare)
Charles University in Prague,Institute of Computer Science of the Czech Academy of Sciences
Manu, Marius Constantin (författare)
Daiichi Sankyo Europe GmbH
visa fler...
Huber, Kurt (författare)
Wilhelminenspital,Sigmund Freud Private University
Rohla, Miklos (författare)
Sigmund Freud Private University,Wilhelminenspital,Karl Landsteiner Gesellschaft Institute for Cardiometabolic Diseases
Renda, Giulia (författare)
University G.d'Annunzio of Chieti-Pescara
Siller-Matula, Jolanta (författare)
Medical University of Warsaw,Medical University of Vienna
Ricci, Fabrizio (författare)
Lund University,Lunds universitet,Kardiovaskulär forskning - hypertoni,Forskargrupper vid Lunds universitet,Cardiovascular Research - Hypertension,Lund University Research Groups,University G.d'Annunzio of Chieti-Pescara
Kirchhof, Paulus (författare)
University Hospitals Birmingham,University of Birmingham,University Medical Center Hamburg-Eppendorf
Caterina, Raffaele De (författare)
University of Pisa
visa färre...
 (creator_code:org_t)
Elsevier BV, 2020
2020
Engelska 7 s.
Ingår i: International Journal of Cardiology. - : Elsevier BV. - 0167-5273. ; 318, s. 67-73
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Background: Data on the relationship between body mass index (BMI), thromboembolic events (TEE) and bleeding in patients with atrial fibrillation (AF) are controversial, and further evidence on the risk of such events in obese patients with AF receiving different anticoagulant therapies (OAC) is needed. Methods and results: We divided a total of 9330 participants from the prospective PREFER in AF and PREFER in AF PROLONGATION registries into BMI quartiles at baseline. Outcome measures were TEE and major bleeding complications at the 1-year follow-up. Without OAC, there was a ≥6-fold increase of TEE in the 4th vs other BMI quartiles (P =.019). OAC equalized the rates of TEE across different BMI strata. The occurrence of major bleeding was highest in patients with BMI in the 1st as well as in the 4th BMI quartile [OR 1.69, 95% CI 1.03–2.78, P =.039 and OR 1.86, 95% CI 1.13–3.04, P =.014 vs those in the 3rd quartile, respectively]. At propensity score-adjusted analysis, the incidence of TEE and major bleeding in obese patients receiving non-vitamin K antagonist oral anticoagulants (NOACs) or vitamin K-antagonist anticoagulants (VKAs) was similar (P ≥.34). Conclusions: Our real-world data suggest no obesity paradox for TEE in patients with AF. Obese patients are at higher risk of TEE, and here OAC dramatically reduces the risk of events. We here found a comparable clinical outcome with NOACs and VKAs in obese patients. Low body weight and obesity were also associated with bleeding, and therefore OAC with the best safety profile should be considered in this setting.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Nyckelord

Atrial fibrillation
Bleeding
Body mass index
Obesity
Oral anticoagulant therapy
Thromboembolic events

Publikations- och innehållstyp

art (ämneskategori)
ref (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy